IGF-1 and retinopathy of prematurity in the preterm infant

Biology of the Neonate

Volumn 88, Issue 3, 2005, Pages 237-244

  Smith, Lois E H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Brain; Insulin like growth factor 1; Mouse model retinopathy of prematurity; Retinopathy of prematurity; Vascular endothelial growth factor

Indexed keywords

SOMATOMEDIN C; VASCULOTROPIN;

ANGIOGENESIS; CELL PROLIFERATION; HUMAN; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA DEVELOPMENT; RETROLENTAL FIBROPLASIA; REVIEW; VASCULARIZATION;

BIRTH WEIGHT; BRAIN; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN-LIKE GROWTH FACTOR I; OXYGEN; RETINA; RETINOPATHY OF PREMATURITY; RISK FACTORS;

EID: 26444577442     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087587     Document Type: Review

References (53)

1. Patz A, Hoeck LE, DeLaCruz E: Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol 1952;35:1248-1252.
2. Flynn JT: Acute proliferative retrolental fibroplasia: multivariate risk analysis. Trans Am Ophthalmol Soc 1983;81:549-591.
3. Michaelson I: The mode of development of the vascular system of the retina, with some observations in its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948;68:137-180.
4. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, et al: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101-111.
5. Ashton N: Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I. Proctor Lecture. Am J Ophthalmol 1966;62:412-435.
6. Penn JS, Tolman BL, Henry MM: Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization. Invest Ophthalmol Vis Sci 1994;35:3429-3435.
7. Langford K, Nicolaides K, Miell JP: Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Hum Reprod 1998;13:1389-1393.
8. Miell JP, Jauniaux E, Langford KS, Westwood M, White A, Jones JS: Insulin-like growth factor binding protein concentration and post-translational modification in embryological fluid. Mol Hum Reprod 1997;3:343-349.
9. Foley TP Jr, DePhilip R, Perricelli A, Miller A: Low somatomedin activity in cord serum from infants with intrauterine growth retardation. J Pediatr 1980;96:605-610.
10. Gluckman PD, Butler JH: Parturition-related changes in insulin-like growth factors-I and -II in the perinatal lamb. J Endocrinol 1983;99:223-232.
11. Gluckman PD, Johnson-Barrett JJ, Butler JH, Edgar BW, Gunn TR: Studies of insulin-like growth factor -I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrinol (Oxf) 1983;19:405-413.
12. Ashton IK, Zapf J, Einschenk I, MacKenzie IZ: Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinol (Copenh) 1985;110:558-563.
13. D'Ercole AJ, Hill DJ, Strain AJ, Underwood LE: Tissue and plasma somatomedin-C/insulin-like growth factor I concentrations in the human fetus during the first half of gestation. Pediatr Res 1986;20:253-255.
14. D'Ercole AJ, Underwood LE: Somatomedin in fetal growth. Pediatr Pulmonol 1985;1(suppl 3):S99-S106.
15. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M: Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991;29:219-225.
16. Wang HS, Lim J, English J, Irvine L, Chard T: The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol 1991;129:459-464.
17. Kubota T, Kamada S, Taguchi M, Aso T: Determination of insulin-like growth factor-2 in feto-maternal circulation during human pregnancy. Acta Endocrinol (Copenh) 1992;127:359-365.
18. Fant M, Salafia C, Baxter RC, Schwander J, Vogel C, Pezzullo J, et al: Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. Regul Pept 1993;48:29-39.
19. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche FA: C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993;169:89-97.
20. Langford K, Blum W, Nicolaides K, Jones J, McGregor A, Miell J: The pathophysiology of the insulin-like growth factor axis in fetal growth failure: a basis for programming by undernutrition? Eur J Clin Invest 1994;24:851-856.
21. Reece EA, Wiznitzer A, Le E, Homko CJ, Behrman H, Spencer EM: The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol 1994;84:88-95.
22. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, et al: Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-1555.
23. Arosio M, Cortelazzi D, Persani L, Palmieri E, Casati G, Baggiani AM, et al: Circulating levels of growth hormone, insulin-like growth factor-I and prolactin in normal, growth retarded and anencephalic human fetuses. J Endocrinol Invest 1995;18:346-353.
24. Nieto-Diaz A, Villar J, Matorras-Weinig R, Valenzuela-Ruiz P: Intrauterine growth retardation at term: association between anthropometric and endocrine parameters. Acta Obstet Gynecol Scand 1996;75:127-131.
25. Ostlund E, Bang P, Hagenas L, Fried G: Insulin-like growth factor I in fetal serum obtained by cordocentesis is correlated with intrauterine growth retardation. Hum Reprod 1997;12:840-844.
26. Lineham JD, Smith RM, Dahlenburg GW, King RA, Haslam RR, Stuart MC, et al: Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally. Early Hum Dev 1986;13:37-46.
27. Smith WJ, Underwood LE, Keyes L, Clemmons DR: Use of insulin-like growth factor I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants. J Clin Endocrinol Metab 1997;82:3982-3988.
28. Hikino S, Ihara K, Yamamoto J, Takahata Y, Nakayama H, Kinukawa N, et al: Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH. Pediatr Res 2001;50:732-736.
29. Hellstrom A, Engstrom E, Hard AL, Albertsson-Wikland K, Carlsson B, Niklasson A, et al: Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003;112:1016-1020.
30. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-848.
31. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-844.
32. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995;92:905-909.
33. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE: Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 1996;93:4851-4856.
34. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, et al: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92:10457-10461.
35. Donahue ML, Phelps DL, Watkins RH, Lo-Monaco MB, Horowitz S: Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy. Curr Eye Res 1996;15:175-184.
36. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E: Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1996;37:290-299.
37. Young TL, Anthony DC, Pierce E, Foley E, Smith LE: Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AA-POS 1997;1:105-110.
38. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, et al: Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996;114:66-71.
39. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders [see comments]. N Engl J Med 1994;331:1480-1487.
40. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, et al: Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995;15:4738-4747.
41. Pierce EA, Foley ED, Smith LE: Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity [see comments] [published erratum appears in Arch Ophthalmol 1997;115:427]. Arch Ophthalmol 1996;114:1219-1228.
42. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-1028.
43. Shih SC, Ju M, Liu N, Mo J-R, Ney J, Smith LE: VEGFR-1 prevents oxygen-induced retinal vascular degeneration - role of TGF-b1 and PlGF-1. J Clin Invest 2003;112:50-57.
44. Sharp PS, Fallon TJ, Brazier OJ, Sandler L, Joplin GF, Kohner EM: Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia 1987;30:199-207.
45. Smith LE, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, et al: Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997;276:1706-1709.
46. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, et al: Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999;5:1390-1395.
47. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, et al: Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001;98:5804-5808.
48. Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, et al: Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 2003;111:1835-1842.
49. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, et al: Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001;98:5804-5808.
50. Hellstrom A, Carlsson B, Niklasson A, Segnestam K, Boguszewski M, de Lacerda L, et al: IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab 2002;87:3413-3416.
51. D'Ercole AJ, Ye P, O'Kusky JR: Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 2002;36:209-220.
52. Popken GJ, Hodge RD, Ye P, Zhang J, Ng W, O'Kusky JR, et al: In vivo effects of insulin-like growth factor-I (IGF-I) on prenatal and early postnatal development of the central nervous system. Eur J Neurosci 2004;19:2056-2068.
53. Doublier S, Duyckaerts C, Seurin D, Binoux M: Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. Growth Horm IGF Res 2000;10:267-274.